Method standardization can be achieved by following a consensus protocol developed by a working group, by performing a molecular test in a centralized laboratory or by using a commercial assay ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

In 2024, Myriad Genetics was awarded three patents related to foundational platform MRD technology and cell-free DNA preparation methods that each enable highly sensitive and specific tumor-informed, ...

Continued innovation and investment in molecular diagnostics will ensure broader access and better preparedness for HMPV, its variants and other respiratory illnesses.

A new molecular test that distinguishes between gene fragments ... set can be assembled into either a car or a plane. “The methods available now can’t distinguish between the variants, so ...

This integration aims to enhance the efficiency of ordering and delivering molecular tests, allowing healthcare providers to electronically place orders, track them, and receive results within an ...

Eurofins Genomics, an international market leader in genomic services, has been accredited the ISO17025:2005 standard since 2007, demonstrating an ...

Abbott also currently offers the FDA-cleared molecular Alinity M STI assay to detect and differentiate between Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma ...

Home > Pressemitteilung: Molecular Bacterial Load Assay: New ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...